Published 4 hours ago • loading... • Updated 2 hours ago
Brain Cancer Patients at UHCW Demand Public Inquiry Into Chemotherapy Scandal
The review found 83 patients received extended temozolomide treatment, and more than 40 are now pursuing legal action.
On Wednesday, the Royal College of Physicians published a report identifying 'serious and systemic failings' within University Hospitals Coventry and Warwickshire NHS Trust's neuro-oncology service, prompting the trust to apologize for these 'failures.'
Retired clinical oncologist Ian Brown administered unnecessary chemotherapy drug temozolomide to brain cancer patients for years, in some cases for 13 years, despite national guidance recommending only six months of treatment.
Of 20 cases examined, 15 were found to have received unsatisfactory care, including patients like Becky Jones who were misdiagnosed; more than 40 patients are now taking legal action against the trust.
Leaders at the UHCW NHS Trust extended their historical review back to 2005 to 'ensure affected patients are identified and supported,' and committed to independent clinical review for all patients treated with over 12 cycles of TMZ.
Patients and lawyers are calling for a public inquiry to investigate how systemic failings persisted for two decades, arguing the review must establish why safeguards failed to intervene sooner.
Dozens of cancer patients in the UK were given chemotherapy for far longer than expected, with some initially diagnosed as having been wrong, a report has claimed.
Serious failings in medical supervision, a lack of patient information and a lack of oversight over treatment decisions have been revealed by a report by the Royal College of Physicians (RCP), prompting calls for a public inquiry.